3.0 High-Efficiency NK Serum-Free Culture Kit | Chapter 1: Cord Blood–Derived CBNK
Release Date:
2026-02-27 16:51
Hycells Biotechnology’s newly launched 3.0 High-Efficiency Serum-Free NK Cell Culture Kit (Catalog No.: NK888-2L), in collaboration with the CBMC Seed Bank, provides a comprehensive, integrated cell culture solution: from thawing and recovering CBMC seed stocks or directly and efficiently expanding fresh CBMCs, to ultimately obtaining NK cells with high purity and high viability. This integrated culture system supports flexible expansion based on cell status, with a scalable culture volume of up to 10 liters, delivering outstanding culture performance and exceptional cost-effectiveness, and earning widespread trust and recognition from customers.
Hycells Biological 3.0 High-Efficiency Version HiXpan Registered trademark The NK serum-free culture kit is manufactured in strict compliance with Good Manufacturing Practice (GMP) and its production system meets relevant guidelines, including the “818 Requirements,” making it suitable for pharmaceutical-grade production and applications.
Sharing of NK Cell Culture Data Derived from Umbilical Cord Blood
Sample source: Ten random fresh or cryopreserved CBMC samples from the Hycells Biological Cell Bank.
NK Kit Catalog Number: NK888-2L
Initial cell count: 38 million–65 million
Cell yield: 15–25 billion
Purity of harvest: 95%–99%
Magnification: 200x–500x
The fluid replacement procedure is shown in the figure below:
Sample 1 (Frozen CBMC)
2511005-D7-220 million
2511005-D19-15.5 billion
Sample 2 (Frozen CBMC)
2511007-D7-250 million
251,100,700,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,......251,100,700,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000......
Sample 3 (Frozen CBMC)
2511011-D7-330 million
251,101.1 million – 18 – 15.84 billion
Sample 4 (Frozen CBMC)
251,200,400 - D7 - 240 million
251,200,400,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,0......251,200,400,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,......
Sample 5 (Frozen CBMC)
251,200,500 - D7 - 170 million
251,200,500,000 – D20 – 16.8 billion
Sample 6 (Frozen CBMC)
251,200,800 - D7 - 350 million
251,200,800,000 - D16 - 18.8 billion
Sample 7 (Frozen CBMC)
251,200,900 - D7 - 440 million
251,200,9-D17-15.6 billion
Sample 8 (Fresh CBMC)
XSCB20260116001-D7-382 million
XSCB20260116001-D18-23.1 billion
Sample 9 (Fresh CBMC)
XSCB260117G-D7-397 million
XSCB260117G-D18-25.3 billion
Sample 10 (Fresh CBMC)
CBMC26010203-D7-352 million
CBMC26010203-D16-16.6 billion
Live Announcement: Integrated Culture of NK Cells
Hycells Biotechnology cordially invites you to join the “Hycells NK Cell Integrated Culture Live Stream,” where we will explore the complete closed-loop process—from sample collection to the production of high-quality cells.
How does Hycells Biotech achieve “one-stop” NK cell culture, streamline the operational workflow, and reduce the risk of contamination? Its proprietary culture system enables high-density expansion of NK cells from a wide range of sample types, with purity exceeding 95%. Technical experts will be live in the broadcast room to address practical challenges in NK cell culture, such as aggregation, slow expansion, and low activity. We simplify processes through cutting-edge technology and validate our capabilities with robust data. On March 10, Hycells invites you to join us in the live stream.
Related News
818 Breakthrough Technology | Integrated Culture Protocol for γδ T Cells
The implementation of the “818 Regulations” marks the official entry of China’s cell therapy industry into a new phase of standardized development, one that prioritizes clinical efficacy as the benchmark for value, upholds rigorous compliance across the entire value chain as an inviolable baseline, and harnesses differentiated technological innovation as the core driver of progress. The Regulations explicitly restrict low-level duplication and homogeneous competition, while giving priority to the translation of technology pathways that demonstrate clear clinical value and outstanding scientific innovation, thereby establishing clear compliance boundaries and a well-defined innovation orientation for the industry’s future development.
Conference Announcement | Hycells cordially invites you to join the 3rd Boao Lecity Stem Cell Summit
From March 20 to 22, 2026, the Third Boao Lecity Stem Cell Conference, co-hosted by the China Anti-Aging Promotion Association and Hainan University, will be held in Boao Lecity, Hainan. With the theme “Cell Therapy Pioneering the Third Medical Revolution,” the conference will also make a major announcement of the latest batch of cell therapy procedures that are now permitted to be billed, thereby establishing an international high-end platform that brings together cutting-edge ideas, translates research into clinical practice, fosters industry collaboration, and jointly develops policies and standards.
A Tribute to the Woman Who Provides “Cell-Level” Protection in the Field of Life Sciences
In the world of biopharmaceuticals, cells are the fundamental units of life; at Hycells Biotechnology, women are the driving force behind global progress. From relentless pursuit in the laboratory to compassionate care on the clinical front lines, women’s sensitivity, resilience, and wisdom—like the “primary cell” technology we have meticulously cultivated—harness the most primal and essential power to propel innovation and shape the future of our field.
Hycells Biotechnology is a biotechnology innovation company specializing in research on primary immune cells and hepatocytes. We are committed to providing customers with comprehensive, one-stop solutions for immune cells and stem cells, leveraging scientific innovation to drive industry development and delivering expert services to empower clinical research.
3.0 High-Efficiency NK Serum-Free Culture Kit | Chapter 1: Cord Blood–Derived CBNK
Hycells Biotechnology’s newly launched 3.0 High-Efficiency Serum-Free NK Cell Culture Kit (Catalog No.: NK888-2L), in collaboration with the CBMC Seed Bank, provides a comprehensive, integrated cell culture solution: from thawing and recovering CBMC seed stocks or directly and efficiently expanding fresh CBMCs, to ultimately obtaining NK cells with high purity and high viability. This integrated culture system supports flexible expansion based on cell status, with a scalable culture volume of up to 10 liters, delivering outstanding culture performance and exceptional cost-effectiveness, and earning widespread trust and recognition from customers.
New Product | Hycells Announces the Launch of High-Viability Primary Hepatocyte Cells!
Within 4 hours after recovery, its cytochrome P450 enzyme activity is most similar to that in vivo, making it suitable for short-term metabolic studies.